{
  "table_name": "bio_component_sequences_30",
  "table_fullname": "bigquery-public-data.ebi_chembl.bio_component_sequences_30",
  "column_names": [
    "component_id",
    "component_type",
    "description",
    "sequence",
    "sequence_md5sum",
    "tax_id",
    "organism"
  ],
  "column_types": [
    "INT64",
    "STRING",
    "STRING",
    "STRING",
    "STRING",
    "INT64",
    "STRING"
  ],
  "nested_column_names": [
    "構成要素_id",
    "構成要素_種類",
    "説明",
    "配列",
    "配列_md5sum",
    "分類_id",
    "生物"
  ],
  "nested_column_types": [
    "INT64",
    "STRING",
    "STRING",
    "STRING",
    "STRING",
    "INT64",
    "STRING"
  ],
  "description": [
    "主キー。ChEMBLにおけるバイオセラピューティクスの各分子成分（例：抗体鎖、組換えタンパク質、合成ペプチド）の一意の識別子。",
    "分子成分の種類（例：'PROTEIN','DNA','RNA'）。",
    "分子成分の説明／名称。",
    "バイオセラピューティクス成分の配列。",
    "配列のMD5チェックサム。",
    "配列が由来する種のNCBI tax ID。ヒト化モノクローナル抗体、合成ペプチド等ではnullの場合がある。",
    "配列が由来する種の名称。"
  ],
  "sample_rows": [
    {
      "構成要素_id": 6288,
      "構成要素_種類": "PROTEIN",
      "説明": "Tigatuzumab light chain",
      "配列": "DIQMTQSPSSLSASVGDRVTITCKASQDVGTAVAWYQQKPGKAPKLLIYWASTRHTGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQQYSSYRTFGQGTKVEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC",
      "配列_md5sum": "19b1591070d7f2a101ea4dbea681e46e",
      "分類_id": null,
      "生物": null
    },
    {
      "構成要素_id": 6293,
      "構成要素_種類": "PROTEIN",
      "説明": "Enavatuzumab heavy chain",
      "配列": "EVQLVESGGGLVQPGGSLRLSCAASGFTFSSYWMSWVRQAPGKGLEWVAEIRLKSDNYATHYAESVKGRFTISRDDSKNSLYLQMNSLRAEDTAVYYCTGYYADAMDYWGQGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKTHTCPPCPAPELLGGPSVFLFPPKPKDTLMISRTPEVTCVVVDVSHEDPEVKFNWYVDGVEVHNAKTKPREEQYNSTYRVVSVLTVLHQDWLNGKEYKCKVSNKALPAPIEKTISKAKGQPREPQVYTLPPSREEMTKNQVSLTCLVKGFYPSDIAVEWESNGQPENNYKTTPPVLDSDGSFFLYSKLTVDKSRWQQGNVFSCSVMHEALHNHYTQKSLSLSPGK",
      "配列_md5sum": "a54c47ebb642b0597fb99b462ee644d0",
      "分類_id": null,
      "生物": null
    },
    {
      "構成要素_id": 6294,
      "構成要素_種類": "PROTEIN",
      "説明": "Enavatuzumab light chain",
      "配列": "DIQMTQSPSSLSASVGDRVTITCRASQSVSTSSYSYMHWYQQKPGKAPKLLIKYASNLESGVPSRFSGSGSGTDFTLTISSLQPEDFATYYCQHSWEIPYTFGGGTKVEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC",
      "配列_md5sum": "a758f6dd8e919ec28c3717fe0a301c5d",
      "分類_id": null,
      "生物": null
    },
    {
      "構成要素_id": 6297,
      "構成要素_種類": "PROTEIN",
      "説明": "Alacizumab pegol f(ab')2 fragment",
      "配列": "EVQLVESGGGLVQPGGSLRLSCAASGFTFSSYGMSWVRQAPGKGLEWVATITSGGSYTYYVDSVKGRFTISRDNAKNTLYLQMNSLRAEDTAVYYCVRIGEDALDYWGQGTLVTVSSASTKGPSVFPLAPSSKSTSGGTAALGCLVKDYFPEPVTVSWNSGALTSGVHTFPAVLQSSGLYSLSSVVTVPSSSLGTQTYICNVNHKPSNTKVDKKVEPKSCDKTHTCAA",
      "配列_md5sum": "492649be3baaaa97804b4f60a77a2118",
      "分類_id": null,
      "生物": null
    },
    {
      "構成要素_id": 6298,
      "構成要素_種類": "PROTEIN",
      "説明": "Alacizumab pegol light chain",
      "配列": "DIQMTQSPSSLSASVGDRVTITCRASQDIAGSLNWLQQKPGKAIKRLIYATSSLDSGVPKRFSGSRSGSDYTLTISSLQPEDFATYYCLQYGSFPPTFGQGTKVEIKRTVAAPSVFIFPPSDEQLKSGTASVVCLLNNFYPREAKVQWKVDNALQSGNSQESVTEQDSKDSTYSLSSTLTLSKADYEKHKVYACEVTHQGLSSPVTKSFNRGEC",
      "配列_md5sum": "6c682f17ba959b62d601da3ccaa799e0",
      "分類_id": null,
      "生物": null
    }
  ]
}